MAVA
LIVE

Serial Number

98664797

Owner

eMAX Health Systems, LLC

Attorney

John Zaccaria

First Use Date

Nov 8, 2018

Filing Date

Jul 24, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MAVA Trademark

Serial Number: 98664797

MAVA is a trademark filed by eMAX Health Systems, LLC on July 24, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

eMAX Health Systems, LLC

1730 S Federal HWY, Suite 273
Delray Beach, FL 33483

Entity Type: 16

Trademark Details

Filing Date

July 24, 2024

Registration Date

Not Registered

First Use Anywhere

November 8, 2018

First Use in Commerce

November 8, 2018

Goods & Services

Platform as a service (PAAS) featuring computer software platforms for providing information in the fields of health insurance, healthcare, medications and pharmaceuticals; Platform as a service (PAAS) featuring computer software platforms for group chats, direct messaging, polls and survey tools in the fields of health insurance, healthcare, medications and pharmaceuticals; Platform as a service (PAAS) featuring computer software platforms for providing access in the nature of scheduling and transmitting messages, images, videos, and documents to and from professionals and experts in the fields of health insurance, healthcare, medications, and pharmaceuticals; Platform as a service (PAAS) featuring computer software platforms for collecting, analyzing and providing information in the fields of health insurance, healthcare, medications and pharmaceuticals

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 28, 2026 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 4, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 4, 2025 GNSL
SUSPENSION LETTER WRITTEN
Sep 4, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 12, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 30, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 30, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 12, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 12, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 12, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 12, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2025 NWOS
NEW APPLICATION ENTERED
Jul 24, 2024 NWAP